ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,354.03
1.18%
US Tech 100
18,555.60
2.10%
Dow Jones
38,807.33
0.25%
Brent Oil
78.635
0.10%
Bitcoin
71,169.52
0.13%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Terns Pharmaceuticals Inc (TERN)

  7. Terns Pharmaceuticals Inc (TERN) News

TERN

Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TERN
DateTimeSourceHeadlineSymbolCompany
06/03/20244:10PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
05/30/20248:05AMGlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
05/17/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics DayNASDAQ:TERNTerns Pharmaceuticals Inc
05/13/20244:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TERNTerns Pharmaceuticals Inc
05/13/20248:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
05/13/20248:05AMGlobeNewswire Inc.Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
05/08/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Announces Leadership ChangesNASDAQ:TERNTerns Pharmaceuticals Inc
05/07/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024NASDAQ:TERNTerns Pharmaceuticals Inc
05/03/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
04/29/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive DifferentiationNASDAQ:TERNTerns Pharmaceuticals Inc
04/10/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
03/14/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
03/11/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid LeukemiaNASDAQ:TERNTerns Pharmaceuticals Inc
03/07/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
03/05/20246:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
02/27/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming March Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
02/15/20246:02PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
02/14/20248:57AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TERNTerns Pharmaceuticals Inc
02/07/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
02/07/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
02/07/20248:05AMGlobeNewswire Inc.Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
02/02/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
01/25/20247:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
01/04/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
01/03/20244:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
11/29/20234:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology SummitNASDAQ:TERNTerns Pharmaceuticals Inc
11/27/20234:05PMGlobeNewswire Inc.Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
11/14/20238:05AMGlobeNewswire Inc.Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
11/13/20238:05AMGlobeNewswire Inc.Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023NASDAQ:TERNTerns Pharmaceuticals Inc
11/09/20238:05AMGlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming November Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TERN

Your Recent History

BOV
H1LT34
Hilton Worldwide
BIT
I08357
Intesa Sanpaolo
COIN
SCLMUSD
Scholeum
EU
ORIA
Fiducial Real Estate
BIT
P1X7K8
NLBNPIT1X7K8 20240619 20...
EU
BE0002733146
Brussels Capital Region ...
ASX
RDX
Redox
TSXV
AXM
AXMIN
ASX
ATM
Aneka Tambang Tbk PT
DBI
I1LL
INAV XT2 EUGOVGREBDL
EU
AEXSH
AEX Short
BIT
P1ZJX1
NLBNPIT1ZJX1 20240621 23
BIT
S30592
Societe Generale Effekten
BIT
P1UOU8
NLBNPIT1UOU8 20241220 30
EU
BEB157601860
Belfius Bank 2.4% Coupon...
USOTC
VCHLF
Value Convergence (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved